| Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference P Wallemacq, VW Armstrong, M Brunet, V Haufroid, DW Holt, A Johnston, ... Therapeutic drug monitoring 31 (2), 139-152, 2009 | 545 | 2009 |
| Amiodarone pharmacokinetics DW Holt, GT Tucker, PR Jackson, GCA Storey American heart journal 106 (4), 840-847, 1983 | 533 | 1983 |
| Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment A Englund, PD Morrison, J Nottage, D Hague, F Kane, S Bonaccorso, ... Journal of psychopharmacology 27 (1), 19-27, 2013 | 529 | 2013 |
| Side effects of long-term amiodarone therapy. L Harris, WJ Mckenna, E Rowland, DW Holt, GC Storey, DM Krikler Circulation 67 (1), 45-51, 1983 | 446 | 1983 |
| Tacrolimus pharmacogenetics: polymorphisms associated with expression of cytochrome p4503A5 and P-glycoprotein correlate with dose requirement IAM Macphee, S Fredericks, T Tai, P Syrris, ND Carter, A Johnston, ... Transplantation 74 (11), 1486-1489, 2002 | 426 | 2002 |
| The acute effects of synthetic intravenous Δ9-tetrahydrocannabinol on psychosis, mood and cognitive functioning PD Morrison, V Zois, DA McKeown, TD Lee, DW Holt, JF Powell, S Kapur, ... Psychological medicine 39 (10), 1607-1616, 2009 | 401 | 2009 |
| Therapeutic drug monitoring of mycophenolate mofetil in transplantation T Van Gelder, Y Le Meur, LM Shaw, M Oellerich, D DeNofrio, C Holt, ... Therapeutic drug monitoring 28 (2), 145-154, 2006 | 396 | 2006 |
| Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation DRJ Kuypers, Y Le Meur, M Cantarovich, MJ Tredger, SE Tett, D Cattaneo, ... Clinical journal of the American Society of Nephrology 5 (2), 341-358, 2010 | 360 | 2010 |
| Comparing mycophenolate mofetil regimens for de novo renal transplant recipients: the fixed-dose concentration-controlled trial T van Gelder, HT Silva, JW de Fijter, K Budde, D Kuypers, G Tyden, ... Transplantation 86 (8), 1043-1051, 2008 | 331 | 2008 |
| The influence of pharmacogenetics on the time to achieve target tacrolimus concentrations after kidney transplantation IAM MacPhee, S Fredericks, T Tai, P Syrris, ND Carter, A Johnston, ... American Journal of Transplantation 4 (6), 914-919, 2004 | 311 | 2004 |
| Current issues in therapeutic drug monitoring of mycophenolic acid: report of a roundtable discussion LM Shaw, DW Holt, M Oellerich, B Meiser, T van Gelder Therapeutic drug monitoring 23 (4), 305-315, 2001 | 304 | 2001 |
| Lake Louise Consensus Conference on cyclosporin monitoring in organ transplantation: report of the consensus panel M Oellerich, VW Armstrong, B Kahan, L Shaw, DW Holt, R Yatscoff, ... Therapeutic drug monitoring 17 (6), 642-654, 1995 | 304 | 1995 |
| Purchasing ‘legal highs’ on the Internet—is there consistency in what you get? S Davies, DM Wood, G Smith, J Button, J Ramsey, R Archer, DW Holt, ... QJM: An International Journal of Medicine 103 (7), 489-493, 2010 | 289 | 2010 |
| Substandard drugs: a potential crisis for public health A Johnston, DW Holt British journal of clinical pharmacology 78 (2), 218-243, 2014 | 280 | 2014 |
| Recreational use of mephedrone (4-methylmethcathinone, 4-MMC) with associated sympathomimetic toxicity DM Wood, S Davies, M Puchnarewicz, J Button, R Archer, H Ovaska, ... Journal of Medical Toxicology 6, 327-330, 2010 | 263 | 2010 |
| Tacrolimus pharmacogenetics: the CYP3A5* 1 allele predicts low dose-normalized tacrolimus blood concentrations in whites and South Asians IAM MacPhee, S Fredericks, M Mohamed, M Moreton, ND Carter, ... Transplantation 79 (4), 499-502, 2005 | 262 | 2005 |
| Plasma concentrations of inflammatory cytokines rise rapidly during ECMO-related SIRS due to the release of preformed stores in the intestine RB McILwain, JG Timpa, AR Kurundkar, DW Holt, DR Kelly, YE Hartman, ... Laboratory investigation 90 (1), 128-139, 2010 | 236 | 2010 |
| Evaluation of fetal arrhythmias by echocardiography. LD Allan, RH Anderson, ID Sullivan, S Campbell, DW Holt, M Tynan Heart 50 (3), 240-245, 1983 | 222 | 1983 |
| Consensus document: Hawk's Cay meeting on therapeutic drug monitoring of cyclosporine BD Kahan, LM Shaw, D Holt, J Grevel, A Johnston Clinical chemistry 36 (8), 1510-1516, 1990 | 205 | 1990 |
| Case series of individuals with analytically confirmed acute mephedrone toxicity DM Wood, S Davies, SL Greene, J Button, DW Holt, J Ramsey, PI Dargan Clinical Toxicology 48 (9), 924-927, 2010 | 192 | 2010 |
